ATYPICAL TERATOID RHABDOID TUMOR
Clinical trials for ATYPICAL TERATOID RHABDOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL TERATOID RHABDOID TUMOR trials appear
Sign up with your email to follow new studies for ATYPICAL TERATOID RHABDOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tots with aggressive brain tumors
Disease control Recruiting nowThis study is testing a new, intensive chemotherapy plan for children under 6 with high-risk brain tumors. The goal is to see if adding a special spinal fluid chemotherapy and a long period of oral 'maintenance' drugs is a workable way to control the cancer. The study will enroll…
Matched conditions: ATYPICAL TERATOID RHABDOID TUMOR
Phase: EARLY_PHASE1 • Sponsor: C17 Council • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for kids with devastating rare cancers
Disease control Recruiting nowThis study is testing a combination of three drugs—tazemetostat, nivolumab, and ipilimumab—as a potential treatment for children and young adults with rare, aggressive cancers caused by missing specific proteins (INI1 or SMARCA4). The first part aims to find the safest dose, and …
Matched conditions: ATYPICAL TERATOID RHABDOID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Susan Chi, MD • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for kids with tough cancers: Two-Drug attack enters trial
Disease control Recruiting nowThis study is testing a new oral drug, AMXT 1501, combined with an existing drug called DFMO, for children and young adults with aggressive cancers that have come back or didn't respond to standard treatments. The first part aims to find a safe dose, and the second part will comp…
Matched conditions: ATYPICAL TERATOID RHABDOID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Doctors test Direct-to-Brain cell therapy for Kids' devastating tumors
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for children and young adults with aggressive or returning brain tumors. Doctors collect a patient's own immune cells, engineer them in a lab to target a protein (B7H3) found on tumor cells, and then deliver these 'CAR T cells'…
Matched conditions: ATYPICAL TERATOID RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New hope for kids with aggressive brain tumors: pioneering therapy delivered directly to the brain
Disease control Recruiting nowThis early-stage study is testing a new type of personalized immune therapy called B7-H3-CAR T cells for children and young adults (up to age 21) with brain tumors that have come back or haven't responded to standard treatments. The therapy involves collecting a patient's own imm…
Matched conditions: ATYPICAL TERATOID RHABDOID TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC